Andrew Rees - 07 Aug 2026 Form 4 Insider Report for Crocs, Inc. (CROX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CROX
Reported as of: 07 Aug 2026
Net transaction value: -$4,154,785
SEC form: 4
Accepted by SEC: 11 Aug 2026, 11:37:59 UTC
Prior SEC filing: 06 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/Sara Hoverstock, Attorney-in-Fact

Key filing fact

Andrew Rees filed Form 4 for Crocs, Inc. (CROX) on 11 Aug 2026.

Key facts

This page summarizes Andrew Rees's Form 4 filing for Crocs, Inc. (CROX).
6 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 11 Aug 2026, 11:37.

Change

Previous filing in this sequence was filed on 06 Aug 2026.
Current net transaction value: -$4,154,785.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001609901 Primary reporting owner

Rees Andrew

Relationship: Chief Executive Officer, Director
Address: C/O CROCS, INC., 500 ELDORADO BLVD #5, BROOMFIELD
Signature: /s/Sara Hoverstock, Attorney-in-Fact
Signature date: 11 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CROX transaction

Common Stock

Sale

Transaction value: $796,453
Shares: -5,796
Change %: -0.78%
Price: $137.41
Shares after: 737,497
Date: 07 Aug 2026
Ownership: By Trust
Footnotes: F1, F2

CROX transaction

Common Stock

Sale

Transaction value: $579,985
Shares: -4,204
Change %: -0.57%
Price: $137.96
Shares after: 733,293
Date: 07 Aug 2026
Ownership: By Trust
Footnotes: F2, F3

CROX transaction

Common Stock

Sale

Transaction value: $129,027
Shares: -928
Change %: -0.13%
Price: $139.04
Shares after: 732,365
Date: 07 Aug 2026
Ownership: By Trust
Footnotes: F2, F4

CROX transaction

Common Stock

Sale

Transaction value: $1,325,138
Shares: -9,576
Change %: -1.3%
Price: $138.38
Shares after: 722,789
Date: 10 Aug 2026
Ownership: By Trust
Footnotes: F2, F5

CROX transaction

Common Stock

Sale

Transaction value: $1,212,168
Shares: -8,696
Change %: -1.2%
Price: $139.39
Shares after: 714,093
Date: 10 Aug 2026
Ownership: By Trust
Footnotes: F2, F6

CROX transaction

Common Stock

Sale

Transaction value: $112,013
Shares: -800
Change %: -0.11%
Price: $140.02
Shares after: 713,293
Date: 10 Aug 2026
Ownership: By Trust
Footnotes: F2, F7

CROX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 570,179
Date: 07 Aug 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.78 - $137.77, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes.

Footnote F2

The reporting person is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power for the shares beneficially owned by the trust.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.79 to $138.10, inclusive.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.01 to $139.14, inclusive.

Footnote F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.00 to $138.98, inclusive.

Footnote F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.00 to $139.96, inclusive.

Footnote F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.00 to $140.05, inclusive.